Who makes API 31510 3% Topical Cream?

API 31510 3% Topical Cream is developed by BPGbio.

What development phase is API 31510 3% Topical Cream in?

API 31510 3% Topical Cream is in Phase 1.

Last reviewed 2026-04-23 · How we verify

API 31510 3% Topical Cream

BPGbio · Phase 1 active Small molecule

At a glance

Generic name	API 31510 3% Topical Cream
Sponsor	BPGbio
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

API 31510 3% Topical Cream CI brief — competitive landscape report
API 31510 3% Topical Cream updates RSS · CI watch RSS
BPGbio portfolio CI